Shu-Sen Wang
- Topics
- Breast Cancer Treatment Studies (3 papers)HER2/EGFR in Cancer Research (2 papers)Breast Lesions and Carcinomas (2 papers)
- Cited by
- Cancer ResearchOncologyDermatology
- Partner nations
- ChinaBrazilUnited States
In The Last Decade
Shu-Sen Wang
8 papers receiving 299 citations
Peers
Comparison fields: 5 of 37
- Oncology 175
- Cancer Research 109
- Pathology and Forensic Medicine 99
- Dermatology 56
- Immunology 52
Countries citing papers authored by Shu-Sen Wang
This map shows the geographic impact of Shu-Sen Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shu-Sen Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shu-Sen Wang more than expected).
Fields of papers citing papers by Shu-Sen Wang
This network shows the impact of papers produced by Shu-Sen Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shu-Sen Wang. The network helps show where Shu-Sen Wang may publish in the future.
Co-authorship network of co-authors of Shu-Sen Wang
This figure shows the co-authorship network connecting the top 25 collaborators of Shu-Sen Wang. A scholar is included among the top collaborators of Shu-Sen Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shu-Sen Wang. Shu-Sen Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 9 | |
| 3 | 153 | |
| 4 | 35 | |
| 5 | 65 | |
| 6 | 33 | |
| 7 | [Clinical characteristics and prognosis of different subtypes of breast cancer]. | 2 |
| 8 | 2 |
About Shu-Sen Wang
Shu-Sen Wang is a scholar working on Cancer Research, Pathology and Forensic Medicine and Oncology, having authored 8 papers that have together received 300 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (3 papers), HER2/EGFR in Cancer Research (2 papers) and Breast Lesions and Carcinomas (2 papers). The work is most often cited by research in Cancer Research (109 citations), Oncology (175 citations) and Dermatology (56 citations). Shu-Sen Wang has collaborated with scholars based in China, Brazil and United States. Frequent co-authors include Roujun Peng, Zhong-Yu Yuan, Tao Qin, Fei Xu, Xin-Ke Zhang, Ge Qin, Cong Xue, Jia-Bin Lu, Li Zhang and Yin-duo Zeng. Their work appears in journals such as The Lancet Oncology, Oncotarget and Journal of Cancer Research and Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.